AUTHOR=Lédée Nathalie , Petitbarat Marie , Prat-Ellenberg Laura , Dray Géraldine , Cassuto Guy N. , Chevrier Lucie , Kazhalawi Alaa , Vezmar Katia , Chaouat Gerard 

TITLE=Endometrial Immune Profiling: A Method to Design Personalized Care in Assisted Reproductive Medicine

JOURNAL=Frontiers in Immunology

VOLUME=11

YEAR=2020

URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.01032

DOI=10.3389/fimmu.2020.01032

ISSN=1664-3224

ABSTRACT=<p><bold>Objective:</bold> To assess the efficiency of the endometrial immune profiling as a method to design personalized care to enhance the pregnancy rate in a large heterogeneous infertile population. We hypothesized that some reproductive failures could be induced by a uterine immune dysregulation which could be identified and corrected with a targeted plan.</p><p><bold>Design:</bold> Prospective cohort study.</p><p><bold>Setting:</bold> Multicentric study.</p><p><bold>Intervention(s) and Main outcome measure(s):</bold> One thousand and seven hundred thirty-eight infertile patients had an immune profiling on a timed endometrial biopsy between 2012 and 2018. This test documented the absence or the presence of an endometrial immune dysregulation and identified its type. In case of dysregulation, a targeted personalized plan was suggested to the treating clinician aiming to supply the anomaly. One year after the test, the clinician was contacted to provide the outcome of the subsequent embryo transfer with the applied suggested plan.</p><p><bold>Result(s):</bold> After testing, 16.5% of the patients showed no endometrial immune dysregulation, 28% had a local immune under-activation, 45% had a local immune over-activation, and 10.5% had a mixed endometrial immune profile. In patients with a history of repeated implantation failures (RIF) or recurrent miscarriages (RM), the pregnancy rate was significantly higher if an endometrial dysregulation was found and the personalized plan applied, compared to the patients with an apparent balanced immune profile (respectively 37.7 and 56% vs. 26.9 and 24%, <italic>p</italic> &lt; 0.001). In contrast, in good prognosis IVF (<italic>in vitro</italic> fertilization) subgroup and patients using donor eggs, this difference was not significant between dysregulated and balanced subgroups, but higher pregnancy rates were observed in absence of dysregulation. For patients with immune over-activation, pregnancy rates were significantly higher for patients who had a test of sensitivity, regarding the type of immunotherapy introduced, when compared to the ones who did not (51 vs. 39.9%, <italic>p</italic> = 0.012).</p><p><bold>Conclusion(s):</bold> Local endometrial immunity appears to be a new and important parameter able to influence the prognosis of pregnancy. Targeted medical care in case of local immune dysregulation resulted in significantly higher pregnancy rates in RIF and RM patients.</p>